VAS-101, a curcumin-based gel for SCD, was well tolerated and showed signs of easing sickle cell pain, fatigue, and red blood ...

Children with sickle cell anemia who undergo stem cell transplant tend to have better long-term cognition than those on ...

The Boozer brothers have joined with NMDP to encourage young adults to register as blood stem cell donors and support ...

Agios Pharmaceuticals’ medication mitapivat rapidly increased levels of the oxygen-carrying protein hemoglobin in patients ages 16 and older with sickle cell disease (SCD), while also being linked to ...

A comparison of sickle cell disease care in the U.S. and Nigeria by columnist Oluwatosin Adesoye revealed a need for more ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

A $1.9-million federal grant has been awarded to a clinical trial that seeks to find effective ways to improve adherence to hydroxyurea treatment among children and young adults with sickle cell ...

More than 1 in 3 children and adolescents with sickle cell disease (SCD) develop retinopathy, or damage to the blood vessels in the retina, the light-sensitive layer of tissue at the back of the eye, ...

A camp in North Carolina offers children living with sickle cell disease the chance to build confidence, independence, and emotional strength while connecting with others who also live with a chronic ...

The U.S. Food and Drug Administration has granted orphan drug status to Kind Pharmaceuticals’ investigational oral small molecule AND017 to treat sickle cell disease (SCD). This designation is granted ...